1,488
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

Early butyrate induced acetylation of histone H4 is proteoform specific and linked to methylation state

ORCID Icon, ORCID Icon & ORCID Icon
Pages 519-535 | Received 22 Mar 2018, Accepted 07 May 2018, Published online: 07 Aug 2018

References

  • Luger K, Mäder AW, Richmond RK, et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature. 1997;389:251–260.
  • Davie JR. Covalent modifications of histones: expression from chromatin templates. Curr Opin Genet Dev. 1998;8:173–178.
  • Vaquero A, Loyola A, Reinberg D. The constantly changing face of chromatin. Sci Aging Knowl Environ. 2003;2003:re4.
  • Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet. 2009;43:559–599.
  • Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381–395.
  • Cosgrove MS, Boeke JD, Wolberger C. Regulated nucleosome mobility and the histone code. Nat Struct Mol Biol. 2004;11:1037–1043.
  • Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci. 51(5):786–794.
  • Gershey EL, Vidali G, Allfrey VG. Chemical studies of histone acetylation. The occurrence of epsilon-N-acetyllysine in the f2a1 histone. J Biol Chem. 1968;243:5018–5022.
  • Andrews AJ, Chen X, Zevin A, et al. The histone chaperone Nap1 promotes nucleosome assembly by eliminating nonnucleosomal histone DNA interactions. Mol Cell. 2010;37:834–842.
  • Peters AH, Kubicek S, Mechtler K, et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Molecular Cell. 2003;12(6):1577–1589.
  • Thiru A, Nietlispach D, Mott HR, et al. Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin. EMBO J. 2004;23:489–499.
  • Stewart MD, Li J, Wong J. Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol Cell Biol. 2005;25:2525–2538.
  • Fischle W, Tseng BS, Dormann HL, et al. Regulation of HP1–chromatin binding by histone H3 methylation and phosphorylation. Nature. 2005;438:1116–1122.
  • Kimura A, Matsubara K, Horikoshi M. A decade of histone acetylation: marking eukaryotic chromosomes with specific codes. J Biochem (Tokyo). 2005;138:647–662.
  • Kleff S, Andrulis ED, Anderson CW, et al. Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem. 1995;270:24674–24677.
  • Brownell JE, Zhou J, Ranalli T, et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell. 1996;84:843–851.
  • Schiltz RL, Mizzen CA, Vassilev A, et al. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem. 1999;274:1189–1192.
  • Daujat S, Bauer U-M, Shah V, et al. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr Biol CB. 2002;12:2090–2097.
  • Ekwall K. Genome-wide analysis of HDAC function. Trends Genet TIG. 2005;21:608–615.
  • Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6(4):a018713.
  • Gajan A, Barnes VL, Liu M, et al. The histone demethylase dKDM5/LID interacts with the SIN3 histone deacetylase complex and shares functional similarities with SIN3. Epigenetics Chromatin. 2016;9(1):4.
  • Lee MG, Wynder C, Bochar DA, et al. Functional interplay between histone demethylase and deacetylase enzymes. Mol Cell Biol. 2006;26:6395–6402.
  • Heerboth S, Lapinska K, Snyder N, et al. Use of epigenetic drugs in disease: an overview. Genet Epigenetics. 2014;6:9–19.
  • Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37:391–400.
  • Sadri-Vakili G, Cha J-HJ. Mechanisms of disease: histone modifications in Huntington’s disease. Nat Clin Pract Neurol. 2006;2:330–338.
  • Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotech. 2010;28:1057–1068.
  • Raha P, Thomas S, Thurn KT, et al. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. Breast Cancer Res. 2015;17:26.
  • Abdelfatah E, Kerner Z, Nanda N, et al. Epigenetic therapy in gastrointestinal cancer: the right combination. Ther Adv Gastroenterol. 2016;9:560–579.
  • Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133:2485S–2493S.
  • Katan-Khaykovich Y, Struhl K. Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors. Genes Dev. 2002;16:743–752.
  • Halsall JA, Turan N, Wiersma M, et al. Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response. Epigenetics Chromatin. 2015;8:29.
  • Zhang L, Su X, Liu S, et al. Histone H4 N-Terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid–urea olyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometry. J Proteome Res. 2007;6:81–88.
  • Fang J, Feng Q, Ketel CS, et al. Purification and functional Characterization of SET8, a nucleosomal histone H4-Lysine 20-Specific methyltransferase. Curr Biol. 2002;12:1086–1099.
  • Garcia BA, Mollah S, Ueberheide BM, et al. Chemical derivatization of histones for facilitated analysis by mass spectrometry. Nat Protoc. 2007;2:933–938.
  • Plazas-Mayorca MD, Zee BM, Young NL, et al. One-pot shotgun quantitative mass spectrometry characterization of histones. J Proteome Res. 2009;8:5367–5374.
  • Sweet SMM, Li M, Thomas PM, et al. Kinetics of Re-establishing H3K79 methylation marks in global human chromatin. J Biol Chem. 2010;285:32778–32786.
  • Sidoli S, Bhanu NV, Karch KR, et al. Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis. JoVE J Vis Exp. 2016;e54112–e54112.
  • Roediger WEW. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982;83:424–429.
  • Schotta G, Lachner M, Sarma K, et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 2004;18:1251–1262.
  • Couppez M, Martin-Ponthieu A, Sautière P. Histone H4 from cuttlefish testis is sequentially acetylated. Comparison with acetylation of calf thymus histone H4. J Biol Chem. 1987;262:2854–2860.
  • Thorne AW, Kmiciek D, Mitchelson K, et al. Patterns of histone acetylation. Eur J Biochem. 1990;193:701–713.
  • Sobel RE, Cook RG, Allis CD. Non-random acetylation of histone H4 by a cytoplasmic histone acetyltransferase as determined by novel methodology. J Biol Chem. 1994;269:18576–18582.
  • Dhalluin C, Carlson JE, Zeng L, et al. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 1999;399:491–496.
  • Jacobson RH, Ladurner AG, King DS, et al. Structure and function of a human TAFII250 double bromodomain module. Science. 2000;288:1422–1425.
  • Owen DJ, Ornaghi P, Yang JC, et al. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 2000;19:6141–6149.
  • Hudson BP, Martinez-Yamout MA, Dyson HJ, et al. Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. J Mol Biol. 2000;304:355–370.
  • Jeanmougin F, Wurtz J-M, Le Douarin B, et al. The bromodomain revisited. Trends Biochem Sci. 1997;22:151–153.
  • Schmidt T, Samaras P, Frejno M, et al. ProteomicsDB. Nucleic Acids Res. 2018;46:D1271–81.
  • Shechter D, Dormann HL, Allis CD, et al. Extraction, purification and analysis of histones. Nat Protoc. 2007;2:1445–1457.
  • DiMaggio PA, Young NL, Baliban RC, et al. A mixed integer linear optimization framework for the identification and quantification of targeted post-translational modifications of highly modified proteins using multiplexed electron transfer dissociation tandem mass spectrometry. Mol Cell Proteomics. 2009;8(11):2527–2543.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.